We have your back, and the way forward has been saved
We have your back, and the way forward
Regulatory compliance services that help you lean in
In June and July of 2020, the US Department of Justice (DOJ) issued two important updates related to the evaluation of corporate compliance. The revised DOJ compliance guidance affects companies across industries, from financial services to life sciences and health care. Explore key takeaways, considerations, and insights to help your organization enable an effective corporate compliance program.
About the DOJ compliance guidance updates
On June 1, 2020, the DOJ updated its guidance document entitled Evaluation of Corporate Compliance Programs (ECCP).1 Subsequently, on July 3, 2020, the DOJ and US Securities and Exchange Commission (SEC) issued an updated version of their 2012 “A Resource Guide to the U.S. Foreign Corrupt Practices Act.”2 As DOJ and SEC’s expectations continue to evolve in both sophistication and granularity with respect to compliance programs, companies may need to make significant or additional investments to keep up.
Our insights focus on the changes in terms of what’s new, related evolving trends, and how you might adapt your corporate compliance program to meet the expectations contained in the new DOJ compliance guidance.
1 US Department of Justice, Criminal Division, “Evaluation of Corporate Compliance Programs, Guidance Document,” June 2020 (updated).
2 Department of Justice, Criminal Division, and US Securities and Exchange Commission, “A Resource Guide to the U.S. Foreign Corrupt Practices Act,” Second Edition – July 2020.
Navigate 2020 DOJ compliance guidance
Help your organization get ahead of DOJ compliance guidance challenges. Learn more about the updates to drive a mature corporate compliance program.